SCIENTIFIC POSTER May 30, 2025 Monitoring botensilimab- and balstilimab-induced T cell dynamics in refractory mismatch repair proficient metastatic colorectal cancer Authors: Gertjan Rasschaert, Ana Mendizabal-Sasieta, Allyson Peddle, Marta Grzelak, Robin Govaerts, Joseph Elan Grossman, Marta Soto, Qian Wu, Benny Johnson, …
Uncover Immune Intelligence
Extend Healthspan
Guide Precision Care
In partnership with Omniscope, Bluegene brings the most advanced immune sequencing platform directly to those who need it most. From clinical researchers, wellness specialists to longevity pioneers; the platform uses AI to uncover patterns in immune cells, offering a deeper understanding of health that was once difficult.
Clinical Insights
Real-time immune signatures for trials, diagnostics, and therapy monitoring. Built for clinicians and researchers.
Longevity and Wellness
Measures immune age, track inflammatory trends, and enhance your healthspan through personalized metrics.
From Within
At bluegene, we’re redefining how immune activity is measured and applied to health. We believe the adaptive immune system holds vital clues into resilience, recovery, and longevity.
By integrating immune sequencing, high-throughput omics, and AI-powered analysis, we deliver a unified platform to decode complex biological signals, making bluegene the partner of choice for next-generation immune and molecular intelligence.
Strategic minds. Decades of impact.One unified mission.
The People Behind bluegene
Our exceptional team is the heartbeat of bleugene, the driving force behind our mission to bring immune intelligence to the forefront of healthcare.
We are scientists, strategists, and business leaders with a shared vision: to make advanced diagnostics and immune profiling more accessible, actionable, and impactful across emerging markets.
With decades of combined experience in global healthcare, we believe that true innovation stems from collaboration, creativity, and deep expertise.
bluegene gives us a new layer of immune insight we’ve never had before. It’s becoming an important tool in how we study patient response to cancer therapies.
Dr. T. A
Associate Professor
United Arab Emirates
The latest
News and Articles
May 26, 2025
Characterizing therapeutic vaccine-elicited HIV-specific CD8+ T cell clonotypes
SCIENTIFIC POSTER May 26, 2025 Characterizing therapeutic vaccine-elicited HIV-specific CD8+ T cell clonotypes Authors: Rafael Tibúrcio, Lily Zemelko, George W. Gruenhagen, Alaa Abdellatif, Gabriella R. Kimmerly, Ravi K. Patel, Ludmila Danilova, Leslie Cope, Juan Luis Melero, Laurent Humeau, Holger …
September 13, 2024
Liquid biopsy tracking of immunotherapy-induced T cell dynamics in MSS colorectal and endometrial tumors
SCIENTIFIC POSTER September 13, 2024 Liquid biopsy tracking of immunotherapy-induced T cell dynamics in MSS colorectal and endometrial tumors Authors: Holger Heyn, Juan Luis Melero, Gerard Deuner, Iosune Baraibar, Marta Grzelak, Ginevra Caratú, Carmen García-Durán, Francisco Grau, David García-Illescas, Lorena …